SightfileU.S. market data from official filings

Companies › CALC

CALCIMEDICA (CALC)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001534133 · EDGAR filings · Updated 2026-07-24

CALCIMEDICA (CALC) has reported institutional ownership of 7.0%, with 27 institutional managers holding positions valued at $592.5K per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
7.0%
Institutional managers
27
Reported 13F value
$592.5K
Insider activity
31 trans.
$247.3K net buying
Data flags
4 active
from SEC filings

Filings this week (3)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CALCIMEDICA has 27 institutional holders and institutional ownership of 7.0%.

Insider activity

Insiders reported 31 transactions (29 buys, 1 sells) across 6 reporting insiders, with a net reported value of $247.3K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-12 (recurring since 2020-11-12) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-03-18 (recurring since 2022-06-21) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2023-05-12 (recurring since 2023-05-12) — source filing. The authoritative details are those stated in the filing itself.
Active material impairment disclosure (8-K Item 2.06), most recently filed 2022-08-23 (recurring since 2022-08-23) — source filing. The authoritative details are those stated in the filing itself.

Related companies

INNOVATIVE EYEWEAR INC (LUCY) · INTERCURE LTD COM NEW (INCR) · Revelation Biosciences Inc (REVB) · Astrotech Corporation (ASTC) · PSYENCE BIOMEDICAL LTD (PBM) · SiNtx Technologies Inc (SINT)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.